Leveraging Artificial Intelligence (AI) to Optimize Phage Therapy: A Perspective.
DOI:
https://doi.org/10.65329/wjeb.v14.02.01Abstract
Phage therapy has its origin around 100 years back as phages were used to treat various infections. However, improper storage, purification methods and treating bacterial infections not specific to the therapeutic phage led to its downfall in the west except in Eastern European countries where it is still being practiced. With the emergence of antimicrobial resistance, the phage therapy once again has attracted the attention of scientists as a promising strategy.
Downloads
References
[1] Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. (2024). Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet (2024) 404:1199–1226. doi: https://doi.org/10.1016/S0140-6736(24)01867-1. PMID: 39299261. DOI: https://doi.org/10.1016/S0140-6736(24)01867-1
[2] Singla, S., Harjai, K., Katare, O. P., & Chhibber, S. (2015). Bacteriophage-loaded nanostructured lipid carrier: improved pharmacokinetics mediates effective resolution of Klebsiella pneumoniae-induced lobar pneumonia. J Infect Dis 212:325–334. doi: https://doi.org/10.1093/infdis/jiv029. PMID: 25605867. DOI: https://doi.org/10.1093/infdis/jiv029
[3] Chhibber S, Kaur J, Kaur S. (2018) Liposome Entrapment of Bacteriophages Improves Wound Healing in a Diabetic Mouse MRSA Infection. Front Microbiol 9:561. doi: https://doi.org/10.3389/fmicb.2018.00561. PMID: 29651276. DOI: https://doi.org/10.3389/fmicb.2018.00561
[4] Pirnay JP. (2020) Phage Therapy in the Year 2035. Front Microbiol 11:1171. doi: 10.3389/fmicb.2020.01171. PMID: 32582107. DOI: https://doi.org/10.3389/fmicb.2020.01171
[5] King SH, Driscoll CL, Li DB, Guo D, Merchant AT, et al. (2026) Generative design of bacteriophages with genome language models. Science 393:eaec2657. doi: https://doi.org/10.1126/science.aec2657. PMID: 42561074. DOI: https://doi.org/10.1126/science.aec2657
[6] Rahimian M, Mohammadi E, Aghazadeh-Soltan-Ahmadi M, Samari A, Zarghami N. (2026) An update on experimental to large-scale production of bacteriophages against superbugs: a review. Crit Rev Biotechnol 46: 25–44. doi: https://doi.org/10.1080/07388551.2025.2531446. PMID: 40759559. DOI: https://doi.org/10.1080/07388551.2025.2531446
[7] Xu S, Yang S, Jiao X, Cai J, Wu J, Qiao J. (2026) From structure to design: experimental and AI-driven approaches in receptor-binding protein engineering for reprogramming phage host range. Arch Microbiol 208:269. doi: https://doi.org/10.1007/s00203-026-04830-9. PMID: 41843138. DOI: https://doi.org/10.1007/s00203-026-04830-9
[8] Galgat H, Pouya N, Tam VH, Nikolaou M. (2026) Using Machine Learning to Design Effective Antimicrobial Dosing Regimens. Comput Chem Eng 210:109645. doi: https://doi.org/10.1016/j.compchemeng.2026.109645. PMID: 42022206 DOI: https://doi.org/10.1016/j.compchemeng.2026.109645
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles in the World Journal of Experimental Biosciences are published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0) ( (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
